Zscaler Total Cost of Revenue increased by 3.5% to $191.26M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 28.8%, from $148.50M to $191.26M. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 42.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $38.98M | $45.48M | $52.17M | $57.78M | $64.02M | $68.31M | $76.70M | $87.60M | $95.85M | $102.68M | $111.39M | $117.20M | $118.33M | $130.21M | $141.46M | $148.50M | $155.98M | $172.24M | $184.75M | $191.26M |
| QoQ Change | — | +16.7% | +14.7% | +10.8% | +10.8% | +6.7% | +12.3% | +14.2% | +9.4% | +7.1% | +8.5% | +5.2% | +1.0% | +10.0% | +8.6% | +5.0% | +5.0% | +10.4% | +7.3% | +3.5% |
| YoY Change | — | — | — | — | +64.3% | +50.2% | +47.0% | +51.6% | +49.7% | +50.3% | +45.2% | +33.8% | +23.5% | +26.8% | +27.0% | +26.7% | +31.8% | +32.3% | +30.6% | +28.8% |